Results
Title

A Phase 1b/2a Study of the CELMoD Iberdomide (CC-220) in Combination With Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma.

Authors

Lonial, Sagar; Van de Donk, Niels; Popat, Rakesh; Zonder, Jeffrey A.; Minnema, Monique; Larsen, Jeremy T.; Nguyen, Tuong Vi; Chen, Min S.; Bensmaine, Amine; Peluso, Teresa; Sonneveld, Pieter

Publication

Clinical Lymphoma, Myeloma & Leukemia, 2019, Vol 19, pe52

ISSN

2152-2650

Publication type

Academic Journal

DOI

10.1016/j.clml.2019.09.080